Markets surge as China's central bank cuts requirements

The markets surged to close sharply higher with Dow rocketing 208 points to 18,034 after China's central bank cut bank reserve requirements. Nasdaq leaped 62 points to 4,994.

On the upside

Novogen (Nasdaq: NVGN) subsidiary CanTx and Yale University announced positive pre-clinical data for its anti-cancer drug Cantrixil.

Shares of Voltari (Nasdaq: VLTC) continued rising.

An appeals court rejected Paul Ceglia's civil suit claiming 50% ownership of Facebook (Nasdaq: FB).

On the downside

Profit taking weighed down shares of Brainstorm Cell Therapeutics (Nasdaq: BCLI).

24/7 Wall Street listed Nektar Therapeutics (Nasdaq: NKTR) as one of five worst performing big biotech firms in 2015.

Shares of Advanced Micro Devices (Nasdaq: AMD) extended its losses.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 soared 19 points to 2100. Bitcoin added $1 to $223.

About this Entry

This page contains a single entry by published on April 20, 2015 1:52 PM.

Chinese investment plan boosts markets was the previous entry in this blog.

Mixed open over Greek concerns is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12